EORTC Endocrine Tumour Group Virtual Meeting

The EORTC Endocrine Tumour Group Virtual Meeting will be held from 14:00 to 17:00 CET.

Programme:

14.00-14.15 Welcome
Speaker: Jan Smit

15.15-15:45 Study portfolio: overview of current trials and discussion on new proposals

EORTC-1953: Predicting tumour progression through molecular profiling in low-risk papillary thyroid cancer during active surveillance

Study update
Funding strategy/opportunities
Feasibility
Speaker: Cosimo Durante

EORTC-1843 (Arcagen): Molecular characterisation of rare cancer
Speaker: Christelle de la Fouchardière

New trial proposals

EORTC-20XX: Lenvatinib vs combo Encorafenib and Binimetinib in BRAF mutated RAI-resistant thyroid cancer
Speaker: Laura Locati

EORTC-RP20XX-proposal for observational study COVID-19 and thyroid cancer
Speaker: Romana Netea Maier

Proposal for a collaboration between EURACAN and EORTC: STarting an Adult Rare Tumor European Registry (STARTER)
Speaker: Trama Annalisa

15:15-15:45 Panel interview new board
Questions and answer session on the board’s strategy / future perspectives
Speaker: Jan Smit

15:45-16:30 EnTG 2020 – 2021

Setting-up monthly working groups

New trial proposals
Publish or perish
Speaker: Ward Sents

EUROPEAN THYROID CANCER WORKSHOP (6 November 2020 – closed section; 13 and 20 November Educational Webinar) Agenda / Programme meeting

How to setup collaborations between ERN + ETA + EORTC
How to tackle unmet needs together
How to setup clinical trials together
How to improve our visibility
Speaker: Laura Locati

SAC review 2020

Scope / Vision / Thoughts
Speaker: Jan Smit

EORTC – New governance structure
Speakers: Ward Sents & Laura Locati

16.30 – 16.40 Update on papers / abstracts
Speaker: Jan Smit

16.40 – 16.50 Next group meeting: time, venue and format
Speaker: Jan Smit

16.50 – 17.00 AOB
Speaker: Jan Smit